[Pluriglandular syndrome of common obesity].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000311:Adrenal Glands / Q000503:physiopathology; D004702:Endocrine Glands / Q000503:physiopathology*; D004700:Endocrine System Diseases / Q000503:physiopathology*; D004967:Estrogens / Q000652:urine; D005260:Female; D005640:Follicle Stimulating Hormone / Q000652:urine; D005951:Glucose Tolerance Test; D006801:Humans; D007037:Hypothyroidism / Q000150:complications; D007328:Insulin / Q000097:blood; D009765:Obesity / Q000097:blood / Q000150:complications / Q000503:physiopathology* / Q000652:urine; D010049:Ovarian Diseases / Q000150:complications / Q000503:physiopathology / Q000652:urine; D011276:Pregnanediol / Q000652:urine
D015065:17-Hydroxycorticosteroids; D004967:Estrogens; D007328:Insulin; D005640:Follicle Stimulating Hormone; D011276:Pregnanediol
Le syndrome pluriglandulaire de l'obésité commune